Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Related structures:
AlphaFold database: Q4Q8Q4
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 9 |
GO:0005488 | binding | 1 | 9 |
GO:0097159 | organic cyclic compound binding | 2 | 9 |
GO:1901363 | heterocyclic compound binding | 2 | 9 |
GO:0003723 | RNA binding | 4 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 50 | 54 | PF00656 | 0.694 |
CLV_NRD_NRD_1 | 11 | 13 | PF00675 | 0.479 |
CLV_NRD_NRD_1 | 17 | 19 | PF00675 | 0.554 |
CLV_NRD_NRD_1 | 190 | 192 | PF00675 | 0.534 |
CLV_NRD_NRD_1 | 44 | 46 | PF00675 | 0.570 |
CLV_NRD_NRD_1 | 6 | 8 | PF00675 | 0.529 |
CLV_NRD_NRD_1 | 78 | 80 | PF00675 | 0.497 |
CLV_PCSK_KEX2_1 | 10 | 12 | PF00082 | 0.529 |
CLV_PCSK_KEX2_1 | 17 | 19 | PF00082 | 0.471 |
CLV_PCSK_KEX2_1 | 189 | 191 | PF00082 | 0.537 |
CLV_PCSK_KEX2_1 | 44 | 46 | PF00082 | 0.570 |
CLV_PCSK_PC7_1 | 7 | 13 | PF00082 | 0.560 |
CLV_PCSK_SKI1_1 | 85 | 89 | PF00082 | 0.412 |
CLV_PCSK_SKI1_1 | 99 | 103 | PF00082 | 0.438 |
DOC_CYCLIN_RxL_1 | 11 | 24 | PF00134 | 0.512 |
DOC_MAPK_gen_1 | 79 | 89 | PF00069 | 0.444 |
DOC_MAPK_MEF2A_6 | 142 | 150 | PF00069 | 0.425 |
DOC_USP7_UBL2_3 | 138 | 142 | PF12436 | 0.553 |
LIG_FHA_1 | 124 | 130 | PF00498 | 0.567 |
LIG_FHA_1 | 84 | 90 | PF00498 | 0.403 |
LIG_FHA_2 | 105 | 111 | PF00498 | 0.500 |
LIG_FHA_2 | 4 | 10 | PF00498 | 0.609 |
LIG_FHA_2 | 45 | 51 | PF00498 | 0.744 |
LIG_RPA_C_Fungi | 20 | 32 | PF08784 | 0.368 |
LIG_SH2_GRB2like | 118 | 121 | PF00017 | 0.374 |
LIG_SH2_STAP1 | 118 | 122 | PF00017 | 0.570 |
LIG_SH2_STAT3 | 118 | 121 | PF00017 | 0.619 |
LIG_SH2_STAT5 | 147 | 150 | PF00017 | 0.489 |
LIG_SH3_3 | 54 | 60 | PF00018 | 0.678 |
LIG_SUMO_SIM_par_1 | 106 | 112 | PF11976 | 0.507 |
MOD_CK1_1 | 94 | 100 | PF00069 | 0.491 |
MOD_CK2_1 | 3 | 9 | PF00069 | 0.574 |
MOD_GlcNHglycan | 38 | 42 | PF01048 | 0.463 |
MOD_GlcNHglycan | 93 | 96 | PF01048 | 0.467 |
MOD_GSK3_1 | 21 | 28 | PF00069 | 0.576 |
MOD_NEK2_1 | 104 | 109 | PF00069 | 0.447 |
MOD_NEK2_1 | 146 | 151 | PF00069 | 0.428 |
MOD_NEK2_1 | 21 | 26 | PF00069 | 0.601 |
MOD_PKA_1 | 44 | 50 | PF00069 | 0.584 |
MOD_PKA_2 | 44 | 50 | PF00069 | 0.709 |
MOD_PKB_1 | 10 | 18 | PF00069 | 0.591 |
MOD_Plk_4 | 104 | 110 | PF00069 | 0.438 |
MOD_Plk_4 | 71 | 77 | PF00069 | 0.544 |
MOD_SUMO_rev_2 | 55 | 64 | PF00179 | 0.675 |
MOD_SUMO_rev_2 | 78 | 84 | PF00179 | 0.603 |
TRG_DiLeu_BaEn_4 | 130 | 136 | PF01217 | 0.534 |
TRG_ENDOCYTIC_2 | 147 | 150 | PF00928 | 0.489 |
TRG_ER_diArg_1 | 10 | 12 | PF00400 | 0.525 |
TRG_ER_diArg_1 | 17 | 19 | PF00400 | 0.506 |
TRG_ER_diArg_1 | 188 | 191 | PF00400 | 0.531 |
TRG_Pf-PMV_PEXEL_1 | 17 | 22 | PF00026 | 0.562 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3Q8IEM8 | Leishmania donovani | 92% | 100% |
A0A422N4H9 | Trypanosoma rangeli | 43% | 70% |
A4HG57 | Leishmania braziliensis | 76% | 100% |
A4I389 | Leishmania infantum | 91% | 100% |
D0A7R5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 41% | 67% |
E9AZH7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 100% |
V5BGL1 | Trypanosoma cruzi | 45% | 70% |